Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
73,000
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,234.60 | 59.50 | 0.73% |
CAC 40 | 7,536.26 | 33.48 | 0.45% |
DAX 40 | 22,242.45 | 177.94 | 0.81% |
Dow JONES (US) | 40,113.50 | 20.10 | 0.05% |
FTSE 100 | 8,415.25 | 7.81 | 0.09% |
HKSE | 21,997.08 | 16.34 | 0.07% |
NASDAQ | 17,382.94 | 216.90 | 1.26% |
Nikkei 225 | 35,843.62 | 137.88 | 0.39% |
NZX 50 Index | 12,097.69 | 79.85 | 0.66% |
S&P 500 | 5,525.21 | 40.44 | 0.74% |
S&P/ASX 200 | 8,028.90 | 60.70 | 0.76% |
SSE Composite Index | 3,294.02 | 1.04 | -0.03% |